Report Overview

The United Kingdom Womens Healthmarket is USD xx billion in 2019 and it is growing at a CAGR of 9.3% during the forecast period (2019-2028).

The UK is one of the major countries in the European region, there are many factors such as rising cancer in women, growth of healthcare infrastructure and so on which augment the UK women health diagnostic market. According to the index of economic freedom, the population of the UK in the year 2018 is around 65.6 million. The UK has few price controls but does regulate rates for most utilities and partly controls the price of prescription drugs. This increases the market player's business activities in this region. Overall net national income is also augmented in this region, this increases the women spending on health, pregnancy and other women related diseases and disorders, which enhances the UK women health diagnostic market during the forecast period.



Market Drivers

The market is majorly driven by the rising burden of Womens Health diseases. Currently, the market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe. The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centres are also expected to support the growth of this market during the forecast period.

Heart diseases are the most common cause of death, it accounts for 1.8 times as many mortalities as the second leading cause of death: dementia and Alzheimer's disease. For females, dementia and Alzheimer's are the common cause of mortalities, followed by heart disease. Cancers accounted for 30% of mortality in males and around 24.8% of mortality in females. When considered separately, 4 of the 10 leading causes of fatality in males and females were cancers. Breast cancer was around the top fatalities in women. Thus, such a high prevalence of diseases is likely to increase the demand for diagnosis and treatment options, which in turn increases the UK women health diagnostics market.

However, the high cost of diagnostic devices, tests, and procedures; shortage of skilled laboratory technicians; and insufficient reimbursements for diagnostic tests are expected to restrain this market's growth to a certain extent.